Combining vestibular rehabilitation with noisy galvanic vestibular stimulation for treatment of bilateral vestibulopathy.

Balance Bilateral vestibulopathy Gait Noisy galvanic vestibular stimulation Vestibular rehabilitation

Journal

Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 29 10 2021
accepted: 15 02 2022
revised: 10 02 2022
pubmed: 26 2 2022
medline: 14 10 2022
entrez: 25 2 2022
Statut: ppublish

Résumé

Noisy galvanic vestibular stimulation (nGVS) has been shown to partly restore vestibular function and to stabilize stance and gait in patients with incomplete bilateral vestibulopathy (BVP). Here, we examined potential synergistic effects of nGVS when combined with standardized vestibular rehabilitation training (VRT). 23 patients with confirmed BVP received a 30-min vestibular rehabilitation training (VRT) program three times a week for 2 weeks. The intervention group (n = 12) was stimulated with nGVS (at individually determined optimal amplitudes) during training, whereas the control group (n = 11) received zero-amplitude nGVS (sham stimulation) during training. Outcome measurements assessed at baseline, after 2 weeks of training, and at 2-week follow-up included quantitative posturography, instrumented gait analysis, Timed Up and Go Test (TUG), Functional Gait Assessment (FGA), and clinical scores related to quality of life and balance confidence. After 2 weeks of VRT, all patients showed moderate improvement in balance. Irrespective of nGVS treatment, performance improved in the TUG (p < 0.013), and in the FGA (p < 0.040). Furthermore, base of support when walking with closed eyes was reduced after 2-week training (p < 0.003). Postural sway did not change. There was no difference between groups and thereby no evidence for an additional influence of nGVS on the VRT treatment effects. nGVS does not induce synergistic treatment effects in combination with VRT in patients with BVP when applied during treatment sessions. Hence, rather than being applied in parallel, nGVS and VRT might be complementary therapeutic options with nGVS being used during postural activities in daily life, e.g., walking.

Identifiants

pubmed: 35212789
doi: 10.1007/s00415-022-11033-x
pii: 10.1007/s00415-022-11033-x
pmc: PMC9553809
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

5731-5737

Subventions

Organisme : Bundesministerium für Bildung und Forschung
ID : 01EO1401

Informations de copyright

© 2022. The Author(s).

Références

PLoS One. 2019 Nov 7;14(11):e0224619
pubmed: 31697727
Curr Treat Options Neurol. 2016 Mar;18(3):13
pubmed: 26920418
NeuroRehabilitation. 2011;29(2):157-66
pubmed: 22027077
J Neurol. 2018 Oct;265(Suppl 1):57-62
pubmed: 29508134
Sci Rep. 2020 Feb 13;10(1):2545
pubmed: 32054910
J Chin Med Assoc. 2013 Jan;76(1):1-8
pubmed: 23331774
Front Neurol. 2018 Mar 01;9:83
pubmed: 29545766
Front Neurol. 2018 Oct 22;9:900
pubmed: 30405522
Neurology. 2014 Mar 18;82(11):969-75
pubmed: 24532279
JAMA Otolaryngol Head Neck Surg. 2013 Aug 1;139(8):803-10
pubmed: 23949355
J Neurol. 2017 Oct;264(Suppl 1):81-86
pubmed: 28391373
J Neurol Phys Ther. 2016 Apr;40(2):124-55
pubmed: 26913496
Brain Stimul. 2018 Jul - Aug;11(4):709-715
pubmed: 29563049
Clin Neurophysiol. 2004 Feb;115(2):267-81
pubmed: 14744566
Neuroscience. 2019 Feb 10;399:161-166
pubmed: 30593921
Otolaryngol Head Neck Surg. 2003 Feb;128(2):240-50
pubmed: 12601321
Phys Ther. 2004 Oct;84(10):906-18
pubmed: 15449976
J Vestib Res. 2017;27(4):177-189
pubmed: 29081426
Laryngoscope. 2001 Oct;111(10):1812-7
pubmed: 11801950
Sci Rep. 2016 Nov 21;6:37575
pubmed: 27869225
Sci Rep. 2019 Nov 20;9(1):17189
pubmed: 31748596
Brain Stimul. 2016 Jan-Feb;9(1):109-16
pubmed: 26422129
Int J Behav Nutr Phys Act. 2011 Oct 21;8:115
pubmed: 22018588
Clin Exp Otorhinolaryngol. 2021 May;14(2):192-199
pubmed: 33197308
Neurology. 2016 Jun 7;86(23):2196-202
pubmed: 27164706
J Vestib Res. 2012;22(5-6):283-98
pubmed: 23302709
J Neurol. 2018 Oct;265(Suppl 1):70-73
pubmed: 29725843
Nature. 1995 Jul 20;376(6537):236-8
pubmed: 7617033
Age Ageing. 2014 Jul;43(4):559-62
pubmed: 24903859

Auteurs

Josefine Eder (J)

German Center for Vertigo and Balance Disorders (DSGZ), Ludwig-Maximilians University of Munich (LMU), University Hospital Grosshadern, Marchioninistrasse 15, 81377, Munich, Germany.

Silvy Kellerer (S)

German Center for Vertigo and Balance Disorders (DSGZ), Ludwig-Maximilians University of Munich (LMU), University Hospital Grosshadern, Marchioninistrasse 15, 81377, Munich, Germany.

Tamara Amberger (T)

German Center for Vertigo and Balance Disorders (DSGZ), Ludwig-Maximilians University of Munich (LMU), University Hospital Grosshadern, Marchioninistrasse 15, 81377, Munich, Germany.
Department of Neurology, Schoen Clinic Bad Aibling, Bad Aibling, Germany.

Aram Keywan (A)

German Center for Vertigo and Balance Disorders (DSGZ), Ludwig-Maximilians University of Munich (LMU), University Hospital Grosshadern, Marchioninistrasse 15, 81377, Munich, Germany.

Julia Dlugaiczyk (J)

German Center for Vertigo and Balance Disorders (DSGZ), Ludwig-Maximilians University of Munich (LMU), University Hospital Grosshadern, Marchioninistrasse 15, 81377, Munich, Germany.
Clinic for Ear, Nose, Throat and Facial Surgery, Interdisciplinary Center for Vertigo and Neurological Disorders, University of Zurich, Zurich, Switzerland.

Max Wuehr (M)

German Center for Vertigo and Balance Disorders (DSGZ), Ludwig-Maximilians University of Munich (LMU), University Hospital Grosshadern, Marchioninistrasse 15, 81377, Munich, Germany.

Klaus Jahn (K)

German Center for Vertigo and Balance Disorders (DSGZ), Ludwig-Maximilians University of Munich (LMU), University Hospital Grosshadern, Marchioninistrasse 15, 81377, Munich, Germany. klaus.jahn@med.uni-muenchen.de.
Department of Neurology, Schoen Clinic Bad Aibling, Bad Aibling, Germany. klaus.jahn@med.uni-muenchen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH